Your browser is no longer supported. Please, upgrade your browser.
Settings
ENZ Enzo Biochem, Inc. daily Stock Chart
ENZ [NYSE]
Enzo Biochem, Inc.
Index- P/E80.30 EPS (ttm)0.03 Insider Own0.10% Shs Outstand47.56M Perf Week-7.99%
Market Cap127.39M Forward P/E- EPS next Y- Insider Trans26.27% Shs Float43.89M Perf Month-6.03%
Income1.50M PEG- EPS next Q- Inst Own61.50% Short Float4.31% Perf Quarter17.26%
Sales80.20M P/S1.59 EPS this Y121.60% Inst Trans-10.25% Short Ratio1.49 Perf Half Y-2.21%
Book/sh1.49 P/B1.78 EPS next Y- ROA1.30% Target Price- Perf Year-23.19%
Cash/sh1.07 P/C2.47 EPS next 5Y- ROE1.90% 52W Range1.56 - 4.85 Perf YTD0.76%
Dividend- P/FCF12.61 EPS past 5Y17.30% ROI1.90% 52W High-45.36% Beta0.78
Dividend %- Quick Ratio2.70 Sales past 5Y-3.30% Gross Margin28.90% 52W Low69.87% ATR0.27
Employees460 Current Ratio3.10 Sales Q/Q0.50% Oper. Margin0.50% RSI (14)43.93 Volatility8.29% 8.42%
OptionableYes Debt/Eq0.07 EPS Q/Q9.30% Profit Margin1.90% Rel Volume0.47 Prev Close2.91
ShortableYes LT Debt/Eq0.06 EarningsMar 09 AMC Payout0.00% Avg Volume1.27M Price2.65
Recom- SMA20-7.28% SMA500.02% SMA200-5.82% Volume591,309 Change-8.93%
Oct-18-11Reiterated Rodman & Renshaw Mkt Outperform $7 → $5
Sep-23-09Initiated Rodman & Renshaw Mkt Outperform $14
Sep-13-07Initiated Lazard Capital Buy $19
Jun-03-20 04:05PM  
May-20-20 08:00AM  
May-12-20 08:00AM  
Apr-29-20 08:00AM  
Apr-23-20 08:00AM  
Mar-24-20 07:50AM  
07:30AM  
Mar-20-20 06:00AM  
01:00AM  
Mar-13-20 07:38PM  
Mar-09-20 02:44PM  
11:42AM  
Mar-06-20 08:00AM  
06:30AM  
Mar-05-20 04:05PM  
Mar-03-20 10:00AM  
Feb-25-20 10:27AM  
09:59AM  
Feb-19-20 05:16PM  
08:30AM  
Feb-12-20 09:18AM  
Feb-11-20 08:30AM  
Feb-07-20 08:00AM  
Feb-06-20 03:07PM  
Jan-30-20 08:13AM  
Jan-29-20 10:51AM  
Jan-28-20 05:45PM  
Jan-27-20 06:45AM  
Jan-21-20 02:36PM  
Jan-17-20 03:02PM  
11:56AM  
Jan-16-20 01:03PM  
Jan-13-20 08:00AM  
Jan-08-20 09:00AM  
08:49AM  
Dec-31-19 10:48AM  
Dec-30-19 09:00AM  
Dec-14-19 07:01PM  
Dec-10-19 04:15PM  
Dec-05-19 04:15PM  
12:00PM  
Nov-09-19 09:18AM  
Oct-17-19 08:44PM  
Oct-15-19 04:15PM  
Oct-11-19 09:00AM  
Oct-10-19 08:06AM  
Sep-24-19 09:00AM  
Sep-17-19 09:00AM  
Sep-10-19 07:33AM  
Aug-15-19 07:43AM  
Aug-05-19 09:00AM  
Jul-17-19 10:48AM  
Jul-11-19 09:00AM  
Jul-02-19 07:12PM  
Jun-11-19 02:54PM  
06:30AM  
Jun-10-19 04:17PM  
Jun-05-19 09:00AM  
May-10-19 10:48AM  
May-02-19 06:00AM  
Apr-23-19 02:19PM  
Apr-01-19 06:25PM  
Mar-11-19 04:50PM  
04:10PM  
Mar-05-19 04:05PM  
Feb-26-19 12:45PM  
Jan-29-19 07:35AM  
Jan-06-19 11:36PM  
Jan-02-19 01:40PM  
Dec-10-18 04:21PM  
04:15PM  
Dec-06-18 09:00AM  
Dec-03-18 09:00AM  
Nov-14-18 12:57PM  
Oct-29-18 08:25AM  
Oct-17-18 08:15AM  
Oct-16-18 09:42PM  
08:52AM  
06:30AM  
Oct-15-18 04:20PM  
04:05PM  
Oct-11-18 12:49PM  
Oct-03-18 07:33PM  
Aug-27-18 08:30AM  
Aug-02-18 08:15AM  
Jul-18-18 09:00AM  
Jul-06-18 07:10AM  
Jun-13-18 06:03AM  
Jun-12-18 08:47AM  
Jun-11-18 04:21PM  
04:10PM  
Jun-06-18 10:00AM  
Apr-24-18 10:00AM  
Mar-14-18 03:58AM  
Mar-13-18 08:04AM  
06:45AM  
Mar-12-18 04:29PM  
04:05PM  
Mar-08-18 04:10PM  
Feb-26-18 07:30AM  
Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates in Life Sciences Products, Clinical Laboratory Services, and Therapeutics segments. The Life Sciences Products segment manufactures, develops, and markets products and tools to clinical research, drug development, and bioscience research customers. It offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide life science researchers tools for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis to life science researchers. This segment provides its products to scientific experts in the fields of cancer, cardiovascular disease, neurological disorders, diabetes and obesity, endocrine disorders, infectious and autoimmune disease, hepatotoxicity, and renal injury. The Clinical Laboratory Services segment provides routine and esoteric clinical laboratory tests or procedures used in general patient care by physicians to establish or support a diagnosis, monitor treatment or medication, or search for an otherwise undiagnosed condition. It operates a full-service clinical laboratory in Farmingdale, New York; a network of approximately 34 patient service centers in New York and New Jersey; and a free standing 'STAT' or rapid response laboratory in New York City and Connecticut, as well as a full-service phlebotomy department. The Therapeutics segment develops novel approaches in the areas of gastrointestinal, infectious, ophthalmic, and metabolic diseases. It markets its products and services through its direct sales force and a network of distributors in the United States and internationally. Enzo Biochem, Inc. was founded in 1976 and is headquartered in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
CLEMENS PETER J IV10% OwnerFeb 18Buy2.204,0008,80015,000Feb 19 02:45 PM
CLEMENS PETER J IV10% OwnerFeb 14Buy2.216,00013,26011,000Feb 19 02:45 PM
HARBERT MANAGEMENT CORP10% OwnerAug 20Buy3.119,70030,1675,620,681Aug 20 05:44 PM
HARBERT MANAGEMENT CORP10% OwnerAug 16Buy3.0622,80069,7685,610,981Aug 20 05:44 PM
HARBERT MANAGEMENT CORP10% OwnerJul 23Buy3.65409,2001,493,5805,588,181Jul 24 12:21 PM
HARBERT MANAGEMENT CORP10% OwnerJul 22Buy3.649,64435,1045,178,981Jul 24 12:21 PM